These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

214 related articles for article (PubMed ID: 6188012)

  • 21. [Combination chemotherapy for advanced diffuse non-Hodgkin's lymphomas in relapse following local radiotherapy].
    Sampi K; Honda T; Hattori M
    Rinsho Hoshasen; 1983 Jun; 28(6):673-7. PubMed ID: 6688641
    [No Abstract]   [Full Text] [Related]  

  • 22. Bleomycin, cisplatin, vincristine, and methotrexate in advanced non-small cell bronchogenic carcinoma.
    Rosenthal CJ; Ritter S; Platica O
    Cancer Treat Rep; 1982 Jan; 66(1):205-6. PubMed ID: 6171350
    [No Abstract]   [Full Text] [Related]  

  • 23. [Chemotherapy in bronchogenic carcinoma (author's transl)].
    Bruntsch U
    Rontgenblatter; 1977 Apr; 30(4):196-201. PubMed ID: 67629
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Long-term survivorship in small-cell anaplastic lung carcinoma.
    Ginsberg SJ; Comis RL; Gottlieb AJ; King GB; Goldberg J; Zamkoff K; Elbadawi A; Meyer JA
    Cancer Treat Rep; 1979 Aug; 63(8):1347-9. PubMed ID: 225029
    [No Abstract]   [Full Text] [Related]  

  • 25. Management of non-small-cell cancer.
    Soukop M
    Recent Results Cancer Res; 1984; 92():79-88. PubMed ID: 6204364
    [No Abstract]   [Full Text] [Related]  

  • 26. [Results of a sequential polychemotherapy (adriamycin, vincristine, cyclophosphamide, methotrexate) in small-cell and undifferentiated bronchial cancer].
    Taytard A; Chomy P; Courty G; Gachie JP; Roquain J
    Rev Fr Mal Respir; 1980; 8(3):225-32. PubMed ID: 6314444
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Lomustine (chloroethylnitrosourea [CCNU]), ifosfamide, bleomycin, vincristine, and cisplatin (CIBO-P) is an effective regimen for patients with poor prognostic refractory or multiple disease recurrent aggressive non-Hodgkin lymphoma.
    Musolino A; Perrone MA; Michiara M; Delnevo D; Franciosi V; Di Blasio B; Ceci G; Camisa R; Ardizzoni A; Cocconi G
    Cancer; 2005 May; 103(10):2109-17. PubMed ID: 15803492
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Polychemotherapy of small-cell lung cancer].
    Krawczyk K; Krochmal M; Pawlicki M; Kulpa J
    Pneumonol Pol; 1983 Feb; 51(2):101-5. PubMed ID: 6308583
    [No Abstract]   [Full Text] [Related]  

  • 29. Management of small cell cancer: intensive chemotherapy.
    Smyth JF; Gregor A
    Recent Results Cancer Res; 1984; 92():58-64. PubMed ID: 6330811
    [No Abstract]   [Full Text] [Related]  

  • 30. Recent therapeutic developments in lung cancer.
    Hansen HH; Selawry OS
    Med Ann Dist Columbia; 1971 Sep; 40(9):580-2. PubMed ID: 4939062
    [No Abstract]   [Full Text] [Related]  

  • 31. Cyclophosphamide, adriamycin, methotrexate, and procarbazine (CAMP) treatment of non-oat cell bronchogenic carcinoma.
    Vogelzang NJ; Bonomi PD; Rossof AH; Wolter J
    Cancer Treat Rep; 1978 Oct; 62(10):1595-7. PubMed ID: 709563
    [No Abstract]   [Full Text] [Related]  

  • 32. Combined modality treatment of small cell carcinoma of the lung.
    Feld R; Pringle JF; Evans WK; Keen CW; Quirt IC; Curtis JE; Baker MA; Yeoh JL; Deboer G; Brown TC
    Arch Intern Med; 1981 Mar; 141(4):469-73. PubMed ID: 6260048
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Results of combined treatment of advanced squamous cell carcinoma of the lung with vincristine, adriamycin and cyclophosphamide].
    Krawczyk K; Krochmal M; Pawlicki M; Kulpa J; Zielezińska A
    Pneumonol Pol; 1983 Feb; 51(2):107-11. PubMed ID: 6878054
    [No Abstract]   [Full Text] [Related]  

  • 34. Randomized study for the treatment of adult advanced Hodgkin's disease: mechlorethamine, vincristine, procarbazine, and prednisone (MOPP) versus lomustine, vinblastine, and prednisone.
    Liebman HA; Hum GJ; Sheehan WW; Ryden VM; Bateman JR
    Cancer Treat Rep; 1983 May; 67(5):413-9. PubMed ID: 6342771
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effects of amphotericin B with combination chemotherapy on response rates and on survival in non-small cell carcinoma of the lung.
    Presant CA; Metter GE; Multhauf P; Bertrand M; Chang FF; Klein L; Rappaport D; Kendregan B; Mackie A
    Cancer Treat Rep; 1984 Apr; 68(4):651-4. PubMed ID: 6201270
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [The course of infectious bronchopulmonary complications during polychemotherapy for bronchogenic carcinoma in immunodepressed patients].
    Salvati F; De Marinis A; Cruciani AR; Fuselli E; Mascherino M; Antilli A
    Arch Monaldi; 1982; 37(3-4):203-8. PubMed ID: 7187738
    [No Abstract]   [Full Text] [Related]  

  • 37. Combination chemotherapy for small cell carcinoma of the lung: continuous versus alternating non-cross-resistant combinations.
    Aisner J; Whitacre M; Van Echo DA; Wiernik PH
    Cancer Treat Rep; 1982 Feb; 66(2):221-30. PubMed ID: 6275987
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Preliminary results in the treatment of oat cell carcinoma of the lung by combined application of chemotherapy (CT) and whole-body hyperthermia.
    Engelhardt R; Neumann H; von der Tann M; Löhr GW
    Prog Clin Biol Res; 1982; 107():761-5. PubMed ID: 6300932
    [No Abstract]   [Full Text] [Related]  

  • 39. [Polychemotherapy and radiotherapy for small cell cancer of the lung].
    Linchenko IF; Danil'ian VM
    Vopr Onkol; 1983; 29(9):106-14. PubMed ID: 6314659
    [No Abstract]   [Full Text] [Related]  

  • 40. [Several years of follow-up and results of chemotherapy of small cell bronchial carcinoma].
    Gatzemeier U
    Prax Klin Pneumol; 1983 Apr; 37(4):144-7. PubMed ID: 6306636
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.